The Effects of Omega-3 Fatty Acids on Aspirin Resistance

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Increased Drug Resistance
Interventions
DRUG

Aspirin

Aspirin 81mg tablet

DRUG

Lovaza

Lovaza 4 grams

DRUG

Both Aspirin and Lovaza

Lovaza 4 grams plus aspirin 81 mg

OTHER

Placebo

Capsule resembling fish oil and a tablet resembling aspirin

Trial Locations (1)

14642

University of Rochester School of Medicine and Dentistry, Rochester

Sponsors
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

collaborator

American College of Clinical Pharmacy

OTHER

collaborator

Cornell University

OTHER

lead

University of Rochester

OTHER